Merck announced that the FDA has approved Grastek (Timothy Grass Pollen Allergen Extract) Tablet for Sublingual Use [2800 Bioequivalent Allergy...
Merck Inc has announced that the FDA's Allergenic Products Committee has voted unanimously to recommend Grastek (sublingual Timothy Grass pollen...
Merck announced that the FDA has accepted for review the Biologics License Application (BLA) for MK-8237, Merck’s house dust mite...